[Combination therapy with insulin and sulfonylurea compounds in type II diabetes mellitus--long-term results].
24 type II diabetic patients who displayed persistent fasting hyperglycaemia on maximal sulphonylurea therapy were treated with a combination of insulin and sulphonylurea agents. Satisfactory control of blood glucose levels was achieved by means of this therapeutic regimen. The good results on carbohydrate metabolism in these patients were maintained over a follow-up period of one year.
Winkler
F
F
5. Medizinische Abteilung, Wilhelminenspitals der Stadt Wien.
Studlar
M
M
D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005905:Glyburide / Q000008:administration & dosage*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D008297:Male
D001786:Blood Glucose; D005905:Glyburide; D006442:Glycated Hemoglobin; D007328:Insulin
Die Kombinationstherapie mit Insulin und Sulfonylharnstoff beim Diabetes mellitus II--Langzeitergebnisse.